2022
DOI: 10.3389/fcimb.2022.898125
|View full text |Cite
|
Sign up to set email alerts
|

Polymyxin Resistance in Clinical Isolates of K. pneumoniae in Brazil: Update on Molecular Mechanisms, Clonal Dissemination and Relationship With KPC-Producing Strains

Abstract: In Brazil, the production of KPC-type carbapenemases in Enterobacteriales is endemic, leading to widespread use of polymyxins. In the present study, 502 Klebsiella pneumoniae isolates were evaluated for resistance to polymyxins, their genetic determinants and clonality, in addition to the presence of carbapenem resistance genes and evaluation of antimicrobial resistance. Resistance to colistin (polymyxin E) was evaluated through initial selection on EMB agar containing 4% colistin sulfate, followed by Minimal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 63 publications
(73 reference statements)
1
3
0
Order By: Relevance
“…When cross-resistance emerges between AMPs and human defensins, it can lead to compromised immune function and challenging-to-manage infections ( Samuelsen et al, 2005 ; Habets and Brockhurst, 2012 ; Fleitas and Franco, 2016 ). Our research aligns with numerous other studies that underscore the widespread occurrence of cross-resistance among AMPs ( Pränting and Andersson, 2010 ; Forsberg et al, 2012 ; Blanco et al, 2020 ; Conceição-Neto et al, 2022 ). Many of the resistance mechanisms associated with AMPs are linked to bacterial nutrient acquisition and the formation of biofilm matrices.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…When cross-resistance emerges between AMPs and human defensins, it can lead to compromised immune function and challenging-to-manage infections ( Samuelsen et al, 2005 ; Habets and Brockhurst, 2012 ; Fleitas and Franco, 2016 ). Our research aligns with numerous other studies that underscore the widespread occurrence of cross-resistance among AMPs ( Pränting and Andersson, 2010 ; Forsberg et al, 2012 ; Blanco et al, 2020 ; Conceição-Neto et al, 2022 ). Many of the resistance mechanisms associated with AMPs are linked to bacterial nutrient acquisition and the formation of biofilm matrices.…”
Section: Discussionsupporting
confidence: 90%
“…A small number of AMP resistance genes that closely resemble known antibiotic resistance genes were identified through our comparison with the Comprehensive Antimicrobial Resistance Database (CARD), indicating the potential for cross-resistance between AMPs and antibiotics. Cross-resistance involves antibiotics such as aminoglycosides (the most common), cephalosporins, tetracyclines, macrolides, and others, as reported in previous studies ( Kubicek-Sutherland et al, 2017 ; Blanco et al, 2020 ; Conceição-Neto et al, 2022 ). The clinical treatment options are undeniably narrowed by this limitation.…”
Section: Discussionmentioning
confidence: 54%
“…Resistance to carbapenems in this species does not occur naturally and is mainly related to the acquisition of βlactamases, the most common of which are carbapenemases, especially Klebsiella pneumoniae carbapenemase (KPC). KPCproducing strains of K. pneumoniae, originally isolated in the USA, have spread and reached a wide geographical distribution (Villegas et al, 2006;Gupta et al, 2011;Nordmann, et al, 2012;Conceição-Neto et al, 2022).…”
Section: Introductionmentioning
confidence: 99%
“…A number of K. pneumoniae strains have been isolated from clinical samples and characterized [ 24 , 25 ]. However, to the best of our knowledge, the current literature in the prevalence and genetic diversity of K. pneumoniae in aquatic animals is little [ 26 ].…”
Section: Introductionmentioning
confidence: 99%